ANTITHROMBOTIC THERAPY IN THE DIABETIC PATIENT: STUDY ON THE EFFECT ON PLATELET FUNCTIONALITY OF A GREATER DOSAGE OF ASPIRIN OR THE ASSOCIATION OF LOW DOSES OF ASPIRIN PLUS SELECTIVE INHIBITOR OF THE COX-2

Trial Profile

ANTITHROMBOTIC THERAPY IN THE DIABETIC PATIENT: STUDY ON THE EFFECT ON PLATELET FUNCTIONALITY OF A GREATER DOSAGE OF ASPIRIN OR THE ASSOCIATION OF LOW DOSES OF ASPIRIN PLUS SELECTIVE INHIBITOR OF THE COX-2

Discontinued
Phase of Trial: Phase III

Latest Information Update: 10 Jul 2014

At a glance

  • Drugs Aspirin (Primary) ; Etoricoxib (Primary)
  • Indications Thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top